Literature DB >> 14255710

EFFECT OF AMINO ACIDS ON STEADY-STATE GROWTH OF A GROUP A HEMOLYTIC STREPTOCOCCUS.

H C Davies, F Karush, J H Rudd.   

Abstract

Davies, Helen C. (University of Pennsylvania, Philadelphia), Fred Karush, and Joanne H. Rudd. Effect of amino acids on steady-state growth of a group A hemolytic streptococcus. J. Bacteriol. 89:421-427. 1965.-A study has been made of amino acid utilization by a strain of type 4, group A streptococcus growing under steady-state conditions in a continuous-culture device and supplied with a completely synthetic medium. At a fixed growth rate, corresponding to a generation of time of 84 min, and with the pH maintained constant at 7.4, the bacterial turbidity was made dependent on the concentration of one of the amino acids of the defined medium. Under these conditions, the extracellular concentration of the limiting amino acid is fixed by the preset growth rate. The steady-state concentration of each of 14 essential l-amino acids was measured by means of C(14)-labeled amino acids in such limited cultures. At approximately equal turbidities, these concentrations ranged from 1.6 x 10(-6)m for methionine to 4.3 x 10(-4)m for glutamic acid. The rates of utilization of the amino acids ranged from 26 mmumoles per mg (dry weight) of bacteria per hr for histidine to 310 mmumoles per mg (dry weight) of bacteria per hr for glutamic acid. The percentage of the limiting amino acid used varied from 95% for threonine and methionine to 43% for gluamic acid. The rate of utilization of the limiting amino acid at unit concentration (tmoles per gram per hour per m) differed by a factor of 27 between extremes. These observations reflect the variation in the capacity of this streptococcal cell to take up and use different amino acids.

Entities:  

Keywords:  AMINO ACIDS; BACTERIOLOGICAL TECHNICS; CARBON ISOTOPES; CULTURE MEDIA; EXPERIMENTAL LAB STUDY; METABOLISM; RADIOMETRY; STREPTOCOCCUS

Mesh:

Substances:

Year:  1965        PMID: 14255710      PMCID: PMC305524          DOI: 10.1128/jb.89.2.421-427.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  9 in total

1.  The amino acid pool in Escherichia coli.

Authors:  R J BRITTEN; F T McCLURE
Journal:  Bacteriol Rev       Date:  1962-09

2.  Extracellular antigens in steady-state cultures of the hemolytic Streptococcus: production of proteinase at low pH.

Authors:  C A OGBURN; T N HARRIS; S HARRIS
Journal:  J Bacteriol       Date:  1958-08       Impact factor: 3.490

3.  Growth of group A hemolytic streptococcus in the steady state.

Authors:  T N HARRIS; V F IACOCCA; F KARUSH
Journal:  J Bacteriol       Date:  1956-09       Impact factor: 3.490

4.  Amino acid metabolic studies. VII. The utilization of amino acids by Streptococcus faecalis under serine imbalance.

Authors:  T A McCOY; M K PATTERSON; L E McCLURE; K L GRIST
Journal:  J Bacteriol       Date:  1954-12       Impact factor: 3.490

5.  The relationship between strepogenin and asparagine.

Authors:  E KODICEK; S P MISTRY
Journal:  Arch Biochem Biophys       Date:  1953-05       Impact factor: 4.013

6.  Peptides and bacterial growth. III. Utilization of tyrosine and tyrosine peptides by Streptococcus faecalis.

Authors:  H KIHARA; O A KLATT; E E SNELL
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

7.  An Improved Medium for the Cultivation of Hemolytic Streptococcus.

Authors:  A W Bernheimer; W Gillman; G A Hottle; A M Pappenheimer
Journal:  J Bacteriol       Date:  1942-04       Impact factor: 3.490

8.  Experiments with the Chemostat on spontaneous mutations of bacteria.

Authors:  A NOVICK; L SZILARD
Journal:  Proc Natl Acad Sci U S A       Date:  1950-12       Impact factor: 11.205

9.  Liquid Scintillation Counting of Tritium-labeled Water and Organic Compounds.

Authors:  F N Hayes; R G Gould
Journal:  Science       Date:  1953-05-01       Impact factor: 47.728

  9 in total
  14 in total

Review 1.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

2.  relA-Independent amino acid starvation response network of Streptococcus pyogenes.

Authors:  K Steiner; H Malke
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

3.  Correlation of M protein production with those factors found to influence growth and substrate utilization of Streptococcus pyogenes.

Authors:  L Pine; M W Reeves
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

4.  Production of streptokinase in continuous culture.

Authors:  B Holmström
Journal:  Appl Microbiol       Date:  1968-01

Review 5.  Continuous cultivation of microorganisms. A review.

Authors:  I Málek; J Ricica
Journal:  Folia Microbiol (Praha)       Date:  1966       Impact factor: 2.099

6.  Growth characteristics of group A streptococci in a new chemically defined medium.

Authors:  I van de Rijn; R E Kessler
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  CovR activation of the dipeptide permease promoter (PdppA) in Group A Streptococcus.

Authors:  Asiya A Gusa; Barbara J Froehlich; Devak Desai; Virginia Stringer; June R Scott
Journal:  J Bacteriol       Date:  2006-09-22       Impact factor: 3.490

8.  Regulation and consequence of serine catabolism in Streptococcus pyogenes.

Authors:  Breah LaSarre; Michael J Federle
Journal:  J Bacteriol       Date:  2011-02-11       Impact factor: 3.490

9.  Streptococcus pyogenes infects human endometrium by limiting the innate immune response.

Authors:  Antonin Weckel; Thomas Guilbert; Clara Lambert; Céline Plainvert; François Goffinet; Claire Poyart; Céline Méhats; Agnès Fouet
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

10.  Synthesis of M protein by group A hemolytic streptococci in completely synthetic media during steady-state growth.

Authors:  H C Davies; F Karush; J H Rudd
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.